Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance

Journal of Clinical Virology

Volumn 50, Issue 3, 2011, Pages 205-208

  Iyer, A ^a   Rajendran, V ^b   Adamson, C S C ^b   Peng, Z ^b   Cooper, K ^b   Evans, M F ^b  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; HPV; Human papillomavirus

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CHROMOGENIC IN SITU HYBRIDIZATION; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN TISSUE; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES; WART VIRUS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; YOUNG ADULT;

EID: 79851513818     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.11.015     Document Type: Article

References (24)

1. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998, 83:2049-2053.
2. Krishnadath K.K., Reid B.J., Wang K.K. Biomarkers in Barrett esophagus. Mayo Clin Proc 2001, 76:438-446.
3. Klump B., Hsieh C.J., Holzmann K., Gregor M., Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 1998, 115:1381-1386.
4. Hardie L.J., Darnton S.J., Wallis Y.L., et al. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations. Cancer Lett 2005, 217:221-230.
5. Younes M., Lebovitz R.M., Lechago L.V., Lechago J. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology 1993, 105:1637-1642.
6. Casson A.G., Mukhopadhyay T., Cleary K.R., Ro J.Y., Levin B., Roth J.A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991, 51:4495-4499.
7. Casson A.G., McCuaig S., Craig I., et al. Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: a prospective study. J Surg Oncol 1994, 56:13-20.
8. Casson A.G., Manolopoulos B., Troster M., et al. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. Am J Surg 1994, 167:52-57.
9. Casson A.G., Evans S.C., Gillis A., et al. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study. J Thorac Cardiovasc Surg 2003, 125:1121-1131.
10. Muzeau F., Flejou J.F., Thomas G., Hamelin R. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers. Int J Cancer 1997, 72:27-30.
11. Gonzalez M.V., Artimez M.L., Rodrigo L., et al. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol 1997, 50:212-217.
12. Barrett M.T., Sanchez C.A., Galipeau P.C., Neshat K., Emond M., Reid B.J. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 1996, 13:1867-1873.
13. Sarbia M., Geddert H., Klump B., Kiel S., Iskender E., Gabbert H.E. Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract. Int J Cancer 2004, 111:224-228.
14. Fischer C.A., Kampmann M., Zlobec I., et al. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010.
15. Chang F., Syrjanen S., Shen Q., et al. Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scand J Gastroenterol 2000, 35:123-130.
16. Farhadi M., Tahmasebi Z., Merat S., Kamangar F., Nasrollahzadeh D., Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005, 11:1200-1203.
17. Turner J.R., Shen L.H., Crum C.P., Dean P.J., Odze R.D. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 1997, 28:174-178.
18. Acevedo-Nuno E., Gonzalez-Ojeda A., Vazquez-Camacho G., Balderas-Pena Luz Ma A., Moreno-Villa H., Montoya-Fuentes H. Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett's oesophagus and oesophagitis. Anticancer Res 2004, 24:1319-1323.
19. Rai N., Jenkins G.J., McAdam E., Hibbitts S.J., Fiander A.N., Powell N.G. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event. J Clin Virol 2008, 43:250-252.
20. de Roda Husman A.M., Snijders P.J., Stel H.V., van den Brule A.J., Meijer C.J., Walboomers J.M. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995, 72:412-417.
21. Evans M.F., Adamson C.S., Simmons-Arnold L., Cooper K. Touchdown general primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol 2005, 5:10.
22. Jacobs M.V., Walboomers J.M., Snijders P.J., et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000, 87:221-227.
23. Evans M.F., Aliesky H.A., Cooper K. Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens. BMC Clin Pathol. 2003, 3(1):2.
24. Matsukura T., Sugase M. Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger. Int J Gynecol Cancer 2008, 18:1042-1050.